← Browse by Condition
Medical Condition
essential thrombocythemia
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3
NCT06734637
Recruiting
Efficacy and Safety of Peginterferon in ET and PV.
Enrollment
40 pts
Location
China
Sponsor
Zhenya Hong
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT06079879 Phase 3
Recruiting
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
Enrollment
340 pts
Location
United States, Argen...
Sponsor
Merck Sharp & Dohme LLC
NCT06552429 Phase 2
Recruiting
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Enrollment
27 pts
Location
China
Sponsor
Xiamen Amoytop Biotech Co., Lt...